A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Recruiting

Phase 1

Cemiplimab, Chemotherapy, ImmunotherapyA Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT04722523

Conditions

Head and Neck Cancer

Head Cancer

Head Cancer Neck

Neck Cancer

Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cisplatin

Carboplatin

Docetaxel

Cetuximab

Cemiplimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-12. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-07-28.